サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1609665

日本のIVD（体外診断）市場レポート：検査タイプ、製品、ユーザビリティ、用途、エンドユーザー、地域別、2025年～2033年

Japan In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 115 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
日本のIVD（体外診断）市場レポート：検査タイプ、製品、ユーザビリティ、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 115 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のIVD（体外診断）市場の市場規模は2024年に50億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに62億1,000万米ドルに達し、2025年から2033年にかけて2.4%の成長率（CAGR）を示すと予測しています。高齢者人口の増加、急速な技術発展、ヘルスケア意識の高まり、政府イニシアチブの増加、個別化薬物療法の開発、研究開発（R&D）活動への注力強化などが市場を牽引する主な要因です。

本レポートで扱う主な質問

  • 日本のIVD（体外診断）市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本のIVD（体外診断）市場に与えた影響は？
  • 日本のIVD（体外診断）市場の検査タイプ別の内訳は？
  • 日本のIVD（体外診断）市場の製品別の内訳は？
  • 日本のIVD（体外診断）市場のユーザビリティ別の内訳は？
  • 日本のIVD（体外診断）市場の用途別内訳は？
  • 日本のIVD（体外診断）市場のエンドユーザー別の内訳は？
  • 日本のIVD（体外診断）市場のバリューチェーンにはどのような段階がありますか？
  • 日本のIVD（体外診断）市場の主な促進要因と課題は何か？
  • 日本のIVD（体外診断）市場の構造と主要プレーヤーは？
  • 日本のIVD（体外診断）市場の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のIVD（体外診断）市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のIVD（体外診断）市場情勢

  • 過去および現在の市場動向（2019年～2024年）
  • 市場予測（2025-2033）

第6章 日本のIVD（体外診断）市場：検査タイプ別の内訳

  • 臨床化学
  • 分子診断
  • 免疫診断
  • 血液学
  • その他

第7章 日本のIVD（体外診断）市場：製品別の内訳

  • 試薬とキット
  • 機器

第8章 日本のIVD（体外診断）市場：ユーザビリティ別の内訳

  • 使い捨てIVDデバイス
  • 再利用可能な体外診断用機器

第9章 日本のIVD（体外診断）市場：用途別の内訳

  • 感染症
  • 糖尿病
  • がん/腫瘍学
  • 心臓病学
  • 自己免疫疾患
  • 腎臓学
  • その他

第10章 日本のIVD（体外診断）市場：エンドユーザー別の内訳

  • 病院研究所
  • 臨床検査室
  • POC検査センター
  • 学術機関
  • 患者
  • その他

第11章 日本のIVD（体外診断）市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第12章 主要企業のプロファイル

第13章 日本のIVD（体外診断）市場- 業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第14章 付録

目次
Product Code: SR112024A11064

The Japan in vitro diagnostics market size reached USD 5.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.21 Billion by 2033, exhibiting a growth rate (CAGR) of 2.4% during 2025-2033. The rising geriatric population, rapid technological advancements, growing healthcare awareness, increasing government initiatives, development of personalized medication, enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.

In vitro diagnostics (IVD) is a collection of medical tests performed using biological samples from the human body. These tests detect diseases, infections, and other medical conditions by analyzing blood, urine, or tissue samples outside the living organism. They are utilized in laboratories, hospitals, and specialized clinics and are vital in medical decision-making, patient monitoring, and personalized treatment. The increasing adoption of IVD in healthcare supports early diagnosis and precise treatment, allowing healthcare providers to make informed and timely decisions. As an essential component of modern healthcare systems, IVD contributes to the advancement of preventive and therapeutic care, enhancing overall patient well-being. It also improves healthcare efficiency, promoting early detection and reducing healthcare costs. It is also employed in monitoring chronic illnesses and assisting in therapeutic decision-making.

Japan In Vitro Diagnostics Market Trends:

The rising geriatric population necessitating more comprehensive and routine medical testing is one of the major factors contributing to the market growth. In line with this, the increasing prevalence of age-related diseases, such as diabetes, cardiovascular conditions, and cancer, prompting increased IVD tests to diagnose and manage these ailments, is propelling the market growth. Additionally, rapid technological advancements in IVD that are introducing innovative solutions with higher accuracy and efficiency, such as innovations in molecular diagnostics, point-of-care (POC) testing, and automation technologies, enhancing the precision, speed, and accessibility of IVD tests, are also creating a positive outlook for the market growth. In addition to this, the increasing government initiatives promoting healthcare innovation and the introduction of user-friendly, personalized IVD solutions are also positively impacting the market growth. Moreover, the growing awareness and emphasis on preventive healthcare as consumers are increasingly proactive in managing their health, leading to higher demand for wellness-related diagnostic tests and personalized medicine solutions, is acting as a growth-inducing factor. Furthermore, the sudden shift towards personalized medicine and the development of molecular diagnostics are shaping the future of the IVD market in Japan. Besides this, the increasing focus on research and development (R&D) and partnerships between diagnostics companies and research institutions are providing remunerative growth opportunities for the market. In addition to this, the integration of big data and artificial intelligence (AI) in diagnostics, enhancing analytical capabilities, and personalizing care is providing remunerative opportunities for the market growth.

Japan In Vitro Diagnostics Market Segmentation:

Test Type Insights:

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunodiagnostics
  • Hematology
  • Others

Product Insights:

  • Reagents and Kits
  • Instruments

Usability Insights:

  • Disposable IVD Devices
  • Reusable IVD Devices

Application Insights:

  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others

End User Insights:

  • Hospitals Laboratories
  • Clinical Laboratories
  • Point-Of-Care Testing Centers
  • Academic Institutes
  • Patients
  • Others

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan in vitro diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan in vitro diagnostics market?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of test type?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of product?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of usability?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of application?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan in vitro diagnostics market?
  • What are the key driving factors and challenges in the Japan in vitro diagnostics market?
  • What is the structure of the Japan in vitro diagnostics market and who are the key players?
  • What is the degree of competition in the Japan in vitro diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan In Vitro Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan In Vitro Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan In Vitro Diagnostics Market - Breakup by Test Type

  • 6.1 Clinical Chemistry
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Molecular Diagnostics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Immunodiagnostics
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Hematology
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2019-2024)
    • 6.5.2 Market Forecast (2025-2033)

7 Japan In Vitro Diagnostics Market - Breakup by Product

  • 7.1 Reagents and Kits
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Instruments
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan In Vitro Diagnostics Market - Breakup by Usability

  • 8.1 Disposable IVD Devices
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Reusable IVD Devices
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan In Vitro Diagnostics Market - Breakup by Application

  • 9.1 Infectious Disease
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Diabetes
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Cancer/Oncology
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Cardiology
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Autoimmune Disease
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2019-2024)
    • 9.5.3 Market Forecast (2025-2033)
  • 9.6 Nephrology
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2019-2024)
    • 9.6.3 Market Forecast (2025-2033)
  • 9.7 Others
    • 9.7.1 Historical and Current Market Trends (2019-2024)
    • 9.7.2 Market Forecast (2025-2033)

10 Japan In Vitro Diagnostics Market - Breakup by End User

  • 10.1 Hospitals Laboratories
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Clinical Laboratories
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Point-of-care Testing Centers
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2019-2024)
    • 10.3.3 Market Forecast (2025-2033)
  • 10.4 Academic Institutes
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2019-2024)
    • 10.4.3 Market Forecast (2025-2033)
  • 10.5 Patients
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2019-2024)
    • 10.5.3 Market Forecast (2025-2033)
  • 10.6 Others
    • 10.6.1 Historical and Current Market Trends (2019-2024)
    • 10.6.2 Market Forecast (2025-2033)

11 Japan In Vitro Diagnostics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan In Vitro Diagnostics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix